These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22931693)

  • 1. Mixed dementia in clinical trials of Alzheimer's disease.
    Massoud F
    Can J Neurol Sci; 2012 Sep; 39(5):566-7. PubMed ID: 22931693
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural imaging markers for therapeutic trials in Alzheimer's disease.
    Fox NC; Kennedy J
    J Nutr Health Aging; 2009 Apr; 13(4):350-2. PubMed ID: 19300877
    [No Abstract]   [Full Text] [Related]  

  • 3. Pre-dementia Alzheimer's trials: overview.
    Aisen PS
    J Nutr Health Aging; 2010 Apr; 14(4):294. PubMed ID: 20305998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genentech's Alzheimer's antibody trial to study disease prevention.
    Garber K
    Nat Biotechnol; 2012 Aug; 30(8):731-2. PubMed ID: 22871696
    [No Abstract]   [Full Text] [Related]  

  • 5. The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions.
    Fargo KN; Carrillo MC; Weiner MW; Potter WZ; Khachaturian Z
    Alzheimers Dement; 2016 Nov; 12(11):1113-1115. PubMed ID: 27836052
    [No Abstract]   [Full Text] [Related]  

  • 6. Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies.
    Quinn JF
    J Alzheimers Dis; 2018; 64(s1):S33-S39. PubMed ID: 29758942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes for disease modifying trials.
    Wilcok G
    J Nutr Health Aging; 2007; 11(4):318-9. PubMed ID: 17653489
    [No Abstract]   [Full Text] [Related]  

  • 8. Sting of Alzheimer's failures offset by upcoming prevention trials.
    Mullard A
    Nat Rev Drug Discov; 2012 Sep; 11(9):657-60. PubMed ID: 22935790
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple pathologies are common in Alzheimer patients in clinical trials.
    Wang BW; Lu E; Mackenzie IR; Assaly M; Jacova C; Lee PE; Beattie BL; Hsiung GY
    Can J Neurol Sci; 2012 Sep; 39(5):592-9. PubMed ID: 22931699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's amyloid immunotherapy: quo vadis?
    Gandy S; Heppner FL
    Lancet Neurol; 2005 Aug; 4(8):452-3. PubMed ID: 16033686
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of physical exercise on executive function in community-dwelling older adults living with Alzheimer's-type dementia: A systematic review.
    Guitar NA; Connelly DM; Nagamatsu LS; Orange JB; Muir-Hunter SW
    Ageing Res Rev; 2018 Nov; 47():159-167. PubMed ID: 30102996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endpoints for trials in Alzheimer's disease: a European task force consensus.
    Vellas B; Andrieu S; Sampaio C; Coley N; Wilcock G;
    Lancet Neurol; 2008 May; 7(5):436-50. PubMed ID: 18420157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of outcome in clinical trials in Alzheimer's disease.
    Snowden JS
    Neuroepidemiology; 1990; 9(4):216-22. PubMed ID: 2215846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunization against Alzheimer's?
    Barinaga M
    Science; 1999 Jul; 285(5425):175, 177. PubMed ID: 10428706
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Alzheimer's disease: general methodological aspects].
    Gauthier S
    Rev Neurol (Paris); 2004 Feb; 160(2):261-4. PubMed ID: 15034487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving long-term care for persons with Alzheimer's disease.
    Sloane PD; Barrick AL
    J Am Geriatr Soc; 1996 Jan; 44(1):91-2. PubMed ID: 8537599
    [No Abstract]   [Full Text] [Related]  

  • 17. Amyloid beta peptide immunotherapy in Alzheimer disease.
    Delrieu J; Ousset PJ; Voisin T; Vellas B
    Rev Neurol (Paris); 2014 Dec; 170(12):739-48. PubMed ID: 25459121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of global assessment measures in dementia drug trials.
    Rockwood K
    J Clin Epidemiol; 1994 Jan; 47(1):101-3. PubMed ID: 8283190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease staging and milestones.
    Rabheru K
    Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S62-6. PubMed ID: 17469685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research design issues: antialuminum drug studies in Alzheimer's disease.
    Shore D; Wyatt RJ
    Clin Neuropharmacol; 1982 Dec; 5(4):337-43. PubMed ID: 7159877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.